Literature DB >> 6488423

Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases.

M Scaglia, R Brustia, S Gatti, A M Bernuzzi, M Strosselli, A Malfitano, D Capelli.   

Abstract

The Pavia District, Northern Italy, is an endemic area of strongyloidiasis. This study reviews the epidemiology and clinics of 150 cases. For this purpose, subjects were categorized for sex, age, origin, profession, acute and chronic disease, symptoms due to larval migration, immunodepression (if present). The incidence, with male predominance (74.7%), peaked among adults (94.6%), and in rural areas (69.3%). Patients experienced digestive (58.6%), cutaneous (34.6%) and respiratory complaints (16.7%). Thiabendazole was successful in most cases, except for 6 gastroresected subjects. Mebendazole at high doses (1 g t. i. d. X 10 days), was no valid alternative drug for 12 patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488423

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  4 in total

1.  Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up.

Authors:  Marina Boscolo; Maria Gobbo; William Mantovani; Monica Degani; Mariella Anselmi; Geraldo Badona Monteiro; Stefania Marocco; Andrea Angheben; Manuela Mistretta; Maria Santacatterina; Stefano Tais; Zeno Bisoffi
Journal:  Clin Vaccine Immunol       Date:  2006-11-29

2.  A retrospective study of autochthonous strongyloïdiasis in Région Midi-Pyrénées (Southwestern France).

Authors:  J F Magnaval; J M Mansuy; L Villeneuve; S Cassaing
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

3.  Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis.

Authors:  R M Genta; D F Frei; M J Linke
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Surveillance of strongyloidiasis in Spanish in-patients (1998-2014).

Authors:  Moncef Belhassen-García; Montserrat Alonso-Sardón; Angela Martinez-Perez; Cristina Soler; Cristina Carranza-Rodriguez; José Luis Pérez-Arellano; Antonio Muro; Fernando Salvador
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.